tiprankstipranks
GlaxoSmithKline (GSK)
NYSE:GSK

GlaxoSmithKline (GSK) Technical Analysis

4,553 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
5Neutral
5Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
GlaxoSmithKline’s (GSK) Moving Averages Convergence Divergence (MACD) indicator is 1.00, suggesting GlaxoSmithKline is a Sell.
GlaxoSmithKline’s (GSK) 20-Day exponential moving average is 43.61, while GlaxoSmithKline’s (GSK) share price is $44.46, making it a Buy.
GlaxoSmithKline’s (GSK) 50-Day exponential moving average is 42.33, while GlaxoSmithKline’s (GSK) share price is $44.46, making it a Buy.

GlaxoSmithKline (GSK) Pivot Points

May 22, 2024, 05:23 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
43.47
43.94
44.26
44.73
45.05
45.52
45.84
Fibonacci
43.94
44.24
44.42
44.73
45.03
45.21
45.52
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

GlaxoSmithKline (GSK) Moving Averages

May 22, 2024, 05:23 AM
Period
Simple
Exponential
MA5
44.85Sell
44.68Sell
MA10
44.71Sell
44.42Buy
MA20
43.33Buy
43.61Buy
MA50
42.07Buy
42.33Buy
MA100
41.09Buy
40.90Buy
MA200
38.02Buy
38.37Buy
GlaxoSmithKline’s (GSK) 10-Day exponential moving average is 44.42, while GlaxoSmithKline’s (GSK) share price is $44.46, making it a Buy.
GlaxoSmithKline’s (GSK) 100-Day exponential moving average is 40.90, while GlaxoSmithKline’s (GSK) share price is $44.46, making it a Buy.
GlaxoSmithKline’s (GSK) stock price is $44.46 and GlaxoSmithKline’s (GSK) 50-day simple moving average is 42.07, creating a Buy signal.
GlaxoSmithKline’s (GSK) stock price is $44.46 and GlaxoSmithKline’s (GSK) 100-day simple moving average is 41.09, creating a Buy signal.
GlaxoSmithKline’s (GSK) stock price is $44.46 and GlaxoSmithKline’s (GSK) 200-day simple moving average is 38.02, creating a Buy signal.

GlaxoSmithKline (GSK) Technical Indicators

May 22, 2024, 05:23 AM
Name
Value
Implied Action
RSI (14)
65.04
Neutral
STOCH (9,6)
30.06
Neutral
STOCHRSI (14)
65.44
Neutral
MACD (12,26)
1.00
Sell
ADX (14)
35.93
Neutral
Williams %R
-46.14
Buy
CCI (14)
48.62
Neutral
ATR (14)
0.72
-
Ultimate Oscillator
29.52
Sell
ROC
5.28
Buy
GlaxoSmithKline’s (GSK) Relative Strength Index (RSI) is 65.04, creating a Neutral signal.
GlaxoSmithKline’s (GSK) Trend Strength Indicator (ADX) is 35.93, creating a Neutral signal.
GlaxoSmithKline’s (GSK) Commodity Channel Index (CCI) is 48.62, creating a Neutral signal.
GlaxoSmithKline’s (GSK) Price Rate of Change (ROC) is 5.28, creating a Buy signal.

FAQ

Is GSK a Buy, Hold, or Sell?
Based on GSK’s technical indicators, GSK is a Buy.
    What is GSK’s RSI (14)?
    GSK’s RSI (14) is 65.04, which suggests GSK is a Neutral.
      What is GSK’s MACD?
      GSK’s MACD is 1.00, which suggests GSK is a Sell.
        What is GSK’s 5-day moving average?
        GSK’s 5-day moving average is 44.85, which suggests GSK is a Sell.
          What is GSK’s 20-day moving average?
          GSK 20-day moving average is 43.33, which suggests GSK is a Buy.
            What is GSK’s 50-day moving average?
            GSK’s 50-day moving average is 42.07, which suggests GSK is a Buy.
              What is GSK’s 200-day moving average?
              GSK’s 200-day moving average is 38.02, which suggests GSK is a Buy.
                What is GSK’s Williams % R (14)?
                GSK’s Williams % R (14) is -46.14, which suggests GSK is a Buy.
                  What is GSK’s CCI (14)?
                  GSK’s CCI (14) is 48.62, which suggests GSK is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis